CFAP119
gene geneOn this page
Also known as MGC104706
Summary
CFAP119 (cilia and flagella associated protein 119, HGNC:28078) is a protein-coding gene on chromosome 16p11.2, encoding Cilia- and flagella-associated protein 119 (A1A4V9).
Predicted to act upstream of or within gene expression; single fertilization; and sperm flagellum assembly. Predicted to be located in acrosomal vesicle and sperm principal piece. Predicted to be part of radial spoke. Predicted to be active in axoneme.
Source: NCBI Gene 90835 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 90 total
- MANE Select transcript:
NM_001014979
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28078 |
| Approved symbol | CFAP119 |
| Name | cilia and flagella associated protein 119 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC104706 |
| Ensembl gene | ENSG00000196118 |
| Ensembl biotype | protein_coding |
| OMIM | 618318 |
| Entrez | 90835 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 10 protein_coding, 6 retained_intron, 1 nonsense_mediated_decay
ENST00000433909, ENST00000535476, ENST00000537986, ENST00000541260, ENST00000543128, ENST00000543610, ENST00000544487, ENST00000544613, ENST00000544643, ENST00000545809, ENST00000545825, ENST00000546006, ENST00000892303, ENST00000892304, ENST00000892305, ENST00000892306, ENST00000957788
RefSeq mRNA: 2 — MANE Select: NM_001014979
NM_001014979, NM_001195620
CCDS: CCDS32434, CCDS55993
Canonical transcript exons
ENST00000543610 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002275386 | 30761545 | 30762062 |
| ENSE00003461330 | 30759012 | 30759101 |
| ENSE00003468137 | 30760606 | 30760668 |
| ENSE00003469179 | 30759654 | 30759724 |
| ENSE00003509236 | 30760284 | 30760453 |
| ENSE00003539414 | 30759178 | 30759247 |
| ENSE00003559032 | 30761198 | 30761229 |
| ENSE00003568724 | 30759342 | 30759458 |
| ENSE00003841363 | 30757423 | 30757654 |
Expression profiles
Bgee: expression breadth ubiquitous, 184 present calls, max score 96.80.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.7017 / max 50.8547, expressed in 1203 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157088 | 2.4409 | 1128 |
| 157089 | 0.1612 | 69 |
| 157090 | 0.0996 | 34 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 96.80 | gold quality |
| bronchial epithelial cell | CL:0002328 | 93.93 | gold quality |
| bronchus | UBERON:0002185 | 93.36 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.05 | gold quality |
| left testis | UBERON:0004533 | 92.03 | gold quality |
| right testis | UBERON:0004534 | 91.92 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.68 | gold quality |
| sperm | CL:0000019 | 90.32 | gold quality |
| pituitary gland | UBERON:0000007 | 89.67 | gold quality |
| testis | UBERON:0000473 | 89.33 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 86.79 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 86.53 | gold quality |
| cerebellar vermis | UBERON:0004720 | 85.83 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.59 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.44 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 84.94 | gold quality |
| vena cava | UBERON:0004087 | 84.81 | gold quality |
| hypothalamus | UBERON:0001898 | 84.77 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.41 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 83.29 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.08 | gold quality |
| substantia nigra | UBERON:0002038 | 82.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 82.63 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 82.59 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 82.49 | gold quality |
| midbrain | UBERON:0001891 | 82.44 | gold quality |
| thyroid gland | UBERON:0002046 | 81.90 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.70 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 81.63 | silver quality |
| metanephros cortex | UBERON:0010533 | 81.61 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.98 |
| E-HCAD-13 | no | 2.97 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cfap119 | ENSDARG00000096777 |
| mus_musculus | Cfap119 | ENSMUSG00000057176 |
| rattus_norvegicus | Cfap119 | ENSRNOG00000053015 |
Paralogs (1): C8orf74 (ENSG00000171060)
Protein
Protein identifiers
Cilia- and flagella-associated protein 119 — A1A4V9 (reviewed: A1A4V9)
Alternative names: Coiled-coil domain-containing protein 189
All UniProt accessions (5): A1A4V9, F5H7A8, H0YGC5, H3BNW1, H3BTQ9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell projection. Cilium. Flagellum. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Cytoplasm.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A1A4V9-1 | 1 | yes |
| A1A4V9-2 | 2 | |
| A1A4V9-3 | 3 | |
| A1A4V9-4 | 4 |
RefSeq proteins (2): NP_001014979, NP_001182549 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032727 | CLAMP | Family |
Pfam: PF14769
UniProt features (10 total): splice variant 4, region of interest 2, chain 1, coiled-coil region 1, modified residue 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A1A4V9-F1 | 74.17 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 34
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 85 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_MALE_GAMETE_GENERATION, GOBP_CILIUM_ORGANIZATION, chr16p11, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, GOBP_FERTILIZATION, GOCC_CYTOPLASMIC_REGION, GOCC_SECRETORY_VESICLE
GO Biological Process (3): single fertilization (GO:0007338), gene expression (GO:0010467), sperm flagellum assembly (GO:0120316)
GO Molecular Function (0):
GO Cellular Component (9): radial spoke (GO:0001534), acrosomal vesicle (GO:0001669), cytoplasm (GO:0005737), sperm principal piece (GO:0097228), cilium (GO:0005929), axoneme (GO:0005930), cytoplasmic vesicle (GO:0031410), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| fertilization | 1 |
| macromolecule biosynthetic process | 1 |
| developmental process involved in reproduction | 1 |
| spermatid development | 1 |
| flagellated sperm motility | 1 |
| motile cilium assembly | 1 |
| axoneme | 1 |
| protein-containing complex | 1 |
| secretory granule | 1 |
| intracellular anatomical structure | 1 |
| sperm flagellum | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
877 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP119 | TMEM95 | Q3KNT9 | 707 |
| CFAP119 | ARMC3 | Q5W041 | 617 |
| CFAP119 | PDZD9 | Q8IXQ8 | 598 |
| CFAP119 | PRSS36 | Q5K4E3 | 571 |
| CFAP119 | TMEM139 | Q8IV31 | 480 |
| CFAP119 | PRSS53 | Q2L4Q9 | 477 |
| CFAP119 | CFAP100 | Q494V2 | 473 |
| CFAP119 | DPY30 | Q9C005 | 463 |
| CFAP119 | LRRIQ4 | A6NIV6 | 445 |
| CFAP119 | MARCHF10 | Q8NA82 | 441 |
| CFAP119 | TMED6 | Q8WW62 | 433 |
| CFAP119 | KCNK17 | Q96T54 | 430 |
| CFAP119 | SPAG17 | Q6Q759 | 391 |
| CFAP119 | RABEP2 | Q9H5N1 | 389 |
| CFAP119 | SLC26A8 | Q96RN1 | 382 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFAP119 | SCGB1D2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFAP119 | TUBA1A | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (4): C16orf93 (Affinity Capture-RNA), SCGB1D2 (Affinity Capture-MS), TUBA1A (Affinity Capture-MS), C16orf93 (Affinity Capture-MS)
ESM2 similar proteins: A1A4V9, A2A8U2, A4IFI1, A8E4X8, B0BMZ6, F1R7R1, G5E8P0, O75161, P12755, P59017, P59240, P85299, P97432, Q14DQ1, Q2HJA5, Q3B7M3, Q3U0L2, Q3ZBK7, Q3ZK22, Q53GS7, Q569K6, Q58DT5, Q5FVG6, Q5RAS2, Q5SNT2, Q5T7N3, Q5XI52, Q60698, Q6NZQ0, Q80U62, Q812A5, Q8C0R7, Q8C190, Q8CC12, Q8IWY9, Q8IYY4, Q8N9B5, Q8NFW9, Q8R1F1, Q8R322
Diamond homologs: A1A4V9, B0BMZ6, Q6NZQ0, Q6P047
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 57 |
| Likely benign | 13 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1618 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:30757650:GTGGC:G | acceptor_gain | 1.0000 |
| 16:30757652:GGC:G | acceptor_gain | 1.0000 |
| 16:30757653:GC:G | acceptor_gain | 1.0000 |
| 16:30757654:CC:C | acceptor_gain | 1.0000 |
| 16:30757655:C:CA | acceptor_loss | 1.0000 |
| 16:30757655:C:CC | acceptor_gain | 1.0000 |
| 16:30757664:C:CT | acceptor_gain | 1.0000 |
| 16:30757665:A:T | acceptor_gain | 1.0000 |
| 16:30759010:A:AC | donor_gain | 1.0000 |
| 16:30759011:C:CC | donor_gain | 1.0000 |
| 16:30759011:CTTGG:C | donor_gain | 1.0000 |
| 16:30759457:CG:C | acceptor_gain | 1.0000 |
| 16:30759459:C:CC | acceptor_gain | 1.0000 |
| 16:30760304:T:TA | donor_gain | 1.0000 |
| 16:30760450:CACC:C | acceptor_gain | 1.0000 |
| 16:30760451:ACC:A | acceptor_gain | 1.0000 |
| 16:30760452:CC:C | acceptor_gain | 1.0000 |
| 16:30760452:CCCT:C | acceptor_gain | 1.0000 |
| 16:30760453:CC:C | acceptor_gain | 1.0000 |
| 16:30760454:C:CA | acceptor_loss | 1.0000 |
| 16:30760454:C:CC | acceptor_gain | 1.0000 |
| 16:30760454:C:T | acceptor_gain | 1.0000 |
| 16:30760455:T:C | acceptor_gain | 1.0000 |
| 16:30760455:T:TC | acceptor_gain | 1.0000 |
| 16:30760604:A:AC | donor_gain | 1.0000 |
| 16:30760604:ACTC:A | donor_gain | 1.0000 |
| 16:30760605:C:CC | donor_gain | 1.0000 |
| 16:30760605:CTCC:C | donor_gain | 1.0000 |
| 16:30760607:C:CA | donor_gain | 1.0000 |
| 16:30760618:G:C | donor_gain | 1.0000 |
AlphaMissense
2155 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:30760301:A:G | L151P | 0.987 |
| 16:30759433:A:G | F189S | 0.986 |
| 16:30761199:A:G | W79R | 0.985 |
| 16:30761199:A:T | W79R | 0.985 |
| 16:30759379:C:G | R207P | 0.984 |
| 16:30759386:A:C | Y205D | 0.983 |
| 16:30760668:C:A | W79C | 0.983 |
| 16:30760668:C:G | W79C | 0.983 |
| 16:30759351:G:C | F216L | 0.981 |
| 16:30759351:G:T | F216L | 0.981 |
| 16:30759353:A:G | F216L | 0.981 |
| 16:30760385:A:G | L123P | 0.980 |
| 16:30759447:G:C | F184L | 0.979 |
| 16:30759447:G:T | F184L | 0.979 |
| 16:30759449:A:G | F184L | 0.979 |
| 16:30759457:C:G | R181P | 0.977 |
| 16:30759365:A:C | Y212D | 0.975 |
| 16:30759382:A:G | F206S | 0.975 |
| 16:30759444:G:C | S185R | 0.974 |
| 16:30759444:G:T | S185R | 0.974 |
| 16:30759446:T:G | S185R | 0.974 |
| 16:30759360:T:A | K213N | 0.973 |
| 16:30759360:T:G | K213N | 0.973 |
| 16:30760362:A:G | C131R | 0.973 |
| 16:30760363:G:C | F130L | 0.973 |
| 16:30760363:G:T | F130L | 0.973 |
| 16:30760365:A:G | F130L | 0.973 |
| 16:30760320:A:G | C145R | 0.972 |
| 16:30759696:G:C | C166W | 0.971 |
| 16:30760346:A:G | F136S | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000558135 (16:30761969 G>C), RS1000992488 (16:30762209 A>C,G,T), RS1001075788 (16:30761500 C>G,T), RS1001191906 (16:30760863 A>C,G), RS1002247475 (16:30761764 T>C,G), RS1002584684 (16:30759380 G>A), RS1002601654 (16:30762019 T>C), RS1003197851 (16:30762935 C>T), RS1003387879 (16:30757525 T>C), RS1003391873 (16:30763563 G>A,C), RS1003422986 (16:30763817 G>A), RS1004041986 (16:30762053 T>C), RS1004531229 (16:30758068 TTC>T), RS1004611577 (16:30763875 C>T), RS1004790704 (16:30758505 T>A)
Disease associations
OMIM: gene MIM:618318 | disease phenotypes: MIM:616172
GenCC curated gene-disease
Mondo (1): generalized epilepsy with febrile seizures plus, type 9 (MONDO:0014517)
Orphanet (1): Genetic epilepsy with febrile seizure plus (Orphanet:36387)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006952_9 | Feeling tense | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009596 | feeling tense measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression | 2 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| belinostat | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): generalized epilepsy with febrile seizures plus, type 9